TLP
RXDX
Tri Locum Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,470
| Closed | -$3.06M | – | 84 |
|
|
2023
Q1 | $3.06M | Buy |
+28,470
| New | +$3.06M | 0.93% | 33 |
|
|
2022
Q4 | – | Sell |
-123,599
| Closed | -$7.29M | – | 91 |
|
|
2022
Q3 | $7.29M | Sell |
123,599
-194,159
| -61% | -$11.5M | 2% | 17 |
|
|
2022
Q2 | $8.97M | Buy |
317,758
+168,692
| +113% | +$4.76M | 3.67% | 10 |
|
|
2022
Q1 | $5.63M | Buy |
+149,066
| New | +$5.63M | 2.2% | 23 |
|